Search Browse Earnings

Guardion Health Sciences, Inc.

Pharmaceutical Preparations·HOUSTON, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Hall Janet

Revenue

$11.0M

+52.8% YoY

FY 2023

Adj. EBITDA

-$17.3M

-156.9% margin

FY 2023

Net Income

-$14.9M

-135.0% margin

FY 2023

EPS (Diluted)

-$14.15

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$10.7M

FY 2023

Total Debt

$14,000

FY 2017

Net Cash

$10.6M

FY 2017

Enterprise Value

—

Debt / EBITDA

0.6x

FY 2023

EV / EBITDA

—

Employees

—